The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Soluble mesothelin neutralizes mesothelin antibody-based therapies.
 
Katherine Emilie Rhoades Smith
No Relationships to Disclose
 
Jennifer Ayers-Ringler
No Relationships to Disclose
 
Paul Dizona
No Relationships to Disclose
 
Fabrice Lucien
No Relationships to Disclose
 
Yohan Kim
No Relationships to Disclose
 
Jacob Orme
Consulting or Advisory Role - NaNotics
Patents, Royalties, Other Intellectual Property - Patents regarding PD-L1 cleavage and immunotherapy resistance in multiple cancers. (Inst)
 
Jeffrey Winters
No Relationships to Disclose
 
Jeffrey Moscow
No Relationships to Disclose
 
Aaron Scott Mansfield
Honoraria - Roche
Consulting or Advisory Role - Abbvie (Inst); AstraZeneca (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Genzyme (Inst); Gilead Sciences (Inst); Janssen (Inst); Johnson & Johnson Global Services (Inst); Takeda (Inst)
Speakers' Bureau - Chugai/Roche (Inst)
Research Funding - Bristol Myers Squibb (Inst); Novartis (Inst); Verily (Inst)
Travel, Accommodations, Expenses - Abbvie; Roche
Other Relationship - Mesothelioma Applied Research Foundation